Caitlyn Chiofolo1, Nicolas Chbat1, Erina Ghosh2, Larry Eshelman2, Kianoush Kashani3. 1. Philips Research North America, Cambridge, MA; Quadrus Medical Technologies, Inc, New York, NY. 2. Philips Research North America, Cambridge, MA. 3. Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, MN; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Mayo Clinic, Rochester, MN. Electronic address: Kashani.kianoush@mayo.edu.
Abstract
OBJECTIVE: To develop and validate a prediction model of acute kidney injury (AKI) of any severity that could be used for AKI surveillance and management to improve clinical outcomes. PATIENTS AND METHODS: This retrospective cohort study was conducted in medical, surgical, and mixed intensive care units (ICUs) at Mayo Clinic in Rochester, Minnesota, including adult (≥18 years of age) ICU-unique patients admitted between October 1, 2004, and April 30, 2011. Our primary objective was prediction of AKI using extant clinical data following ICU admission. We used random forest classification to provide continuous AKI risk score. RESULTS: We included 4572 and 1958 patients in the training and validation mutually exclusive cohorts, respectively. Acute kidney injury occurred in 1355 patients (30%) in the training cohort and 580 (30%) in the validation cohort. We incorporated known AKI risk factors and routinely measured vital characteristics and laboratory results. The model was run throughout ICU admission every 15 minutes and achieved an area under the receiver operating characteristic curve of 0.88 on validation. It was 92% sensitive and 68% specific and detected 30% of AKI cases at least 6 hours before the criterion standard time (AKI stages 1-3). For discrimination of AKI stages 2 to 3, the model had 91% sensitivity, 71% specificity, and 53% detection of AKI cases at least 6 hours before AKI onset. CONCLUSION: We developed and validated an AKI prediction model using random forest for continuous monitoring of ICU patients. This model could be used to identify high-risk patients for preventive measures or identifying patients of prospective interventional trials.
OBJECTIVE: To develop and validate a prediction model of acute kidney injury (AKI) of any severity that could be used for AKI surveillance and management to improve clinical outcomes. PATIENTS AND METHODS: This retrospective cohort study was conducted in medical, surgical, and mixed intensive care units (ICUs) at Mayo Clinic in Rochester, Minnesota, including adult (≥18 years of age) ICU-unique patients admitted between October 1, 2004, and April 30, 2011. Our primary objective was prediction of AKI using extant clinical data following ICU admission. We used random forest classification to provide continuous AKI risk score. RESULTS: We included 4572 and 1958 patients in the training and validation mutually exclusive cohorts, respectively. Acute kidney injury occurred in 1355 patients (30%) in the training cohort and 580 (30%) in the validation cohort. We incorporated known AKI risk factors and routinely measured vital characteristics and laboratory results. The model was run throughout ICU admission every 15 minutes and achieved an area under the receiver operating characteristic curve of 0.88 on validation. It was 92% sensitive and 68% specific and detected 30% of AKI cases at least 6 hours before the criterion standard time (AKI stages 1-3). For discrimination of AKI stages 2 to 3, the model had 91% sensitivity, 71% specificity, and 53% detection of AKI cases at least 6 hours before AKI onset. CONCLUSION: We developed and validated an AKI prediction model using random forest for continuous monitoring of ICU patients. This model could be used to identify high-risk patients for preventive measures or identifying patients of prospective interventional trials.
Authors: Kathleen D Liu; Stuart L Goldstein; Anitha Vijayan; Chirag R Parikh; Kianoush Kashani; Mark D Okusa; Anupam Agarwal; Jorge Cerdá Journal: Clin J Am Soc Nephrol Date: 2020-04-21 Impact factor: 8.237
Authors: Sidney Le; Angier Allen; Jacob Calvert; Paul M Palevsky; Gregory Braden; Sharad Patel; Emily Pellegrini; Abigail Green-Saxena; Jana Hoffman; Ritankar Das Journal: Kidney Int Rep Date: 2021-02-26
Authors: Ugochukwu Ugwuowo; Yu Yamamoto; Tanima Arora; Ishan Saran; Caitlin Partridge; Aditya Biswas; Melissa Martin; Dennis G Moledina; Jason H Greenberg; Michael Simonov; Sherry G Mansour; Ricardo Vela; Jeffrey M Testani; Veena Rao; Keith Rentfro; Wassim Obeid; Chirag R Parikh; F Perry Wilson Journal: Am J Kidney Dis Date: 2020-06-04 Impact factor: 8.860
Authors: Peter Pickkers; Michael Darmon; Eric Hoste; Michael Joannidis; Matthieu Legrand; Marlies Ostermann; John R Prowle; Antoine Schneider; Miet Schetz Journal: Intensive Care Med Date: 2021-07-02 Impact factor: 17.440
Authors: Hossam Abdou; Noha N Elansary; Louisa Darko; Joseph J DuBose; Thomas M Scalea; Jonathan J Morrison; Rishi Kundi Journal: Trauma Surg Acute Care Open Date: 2021-07-15